Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer

Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer

Emerging data suggest that circulating tumor DNA (ctDNA) can detect colorectal cancer (CRC)-specific signals across both non-metastatic and metastatic settings. With the development of multiple platforms, including tumor-informed and tumor-agnostic ctDNA assays and demonstration of their provocative...

Full description

Bibliographic Details
Main Authors: Jun Gong, Andrew Hendifar, Alexandra Gangi, Karen Zaghiyan, Katelyn Atkins, Yosef Nasseri, Zuri Murrell, Jane C. Figueiredo, Sarah Salvy, Robert Haile, Megan Hitchins
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
circulating tumor DNA
minimal residual disease
tumor-informed
tumor-agnostic
colorectal cancer
Online Access:https://www.mdpi.com/2072-6694/13/18/4547

Internet

https://www.mdpi.com/2072-6694/13/18/4547

Similar Items